Key result
TFE3 immunohistochemistry showed false-positive results for Xp11.2 translocation renal cell carcinoma, which was definitively ruled out by a negative FISH assay.
Case Report (n=1)
Describes a rare subtype of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion (Xp11.2 RCC) is a rare subtype of RCC which is delineated as a distinct entity in the 2004 World Health Organization renal tumor classification.
No takes yet. Share an insight, caveat, or question.
Zattar et al. (2021) conducted a case report in Renal cell carcinoma (n=1). TFE3 immunohistochemistry was evaluated on Diagnosis of Xp11.2 translocation RCC. TFE3 immunohistochemistry showed false-positive results for Xp11.2 translocation renal cell carcinoma, which was definitively ruled out by a negative FISH assay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: